Section Arrow
VXRT.NASDAQ
- Vaxart
Quotes are at least 15-min delayed:2024/04/29 01:13 EDT
Last
 0.7097
+0.0513 (+7.79%)
Day High 
0.7097 
Prev. Close
0.6584 
1-M High
1.41 
Volume 
1.32M 
Bid
0.71
Ask
0.72
Day Low
0.6603 
Open
0.6985 
1-M Low
0.6331 
Market Cap 
114.47M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.81 
20-SMA 0.98 
50-SMA 1.12 
52-W High 1.59 
52-W Low 0.53 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.57/-0.60
Enterprise Value
131.86M
Balance Sheet
Book Value Per Share
0.33
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.38M
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8601+0.0824+10.60%-- 
BDRXBiodexa Pharmaceuticals plc1.3+0.5752+79.36%-- 
KTRAKintara Therapeutics0.1488-0.0092-5.82%-- 
JAGXJaguar Health0.18+0.01+5.88%-- 
IBRXImmunityBio7.35+2.24+43.84%-- 
Quotes are at least 15-min delayed:2024/04/29 01:13 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.